Status:
COMPLETED
Virtual Darkness as Additive Treatment in Mania
Lead Sponsor:
Helse Fonna
Collaborating Sponsors:
University of Bergen
Helse Vest
Conditions:
Bipolar Disorder
Mania
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
In this randomized controlled study we will investigate the effect of blue-blocking goggles or screens (virtual darkness therapy) on manic symptoms in bipolar disorder compared to placebo. This 3-arme...
Detailed Description
Recent discoveries in neurophysiology has shown that "virtual darkness" is achievable by blocking blue wavelengths of light (Phelps, 2007). A newly discovered retinal photoreceptor called the Intrinsi...
Eligibility Criteria
Inclusion
- PATIENT GROUPS
- Inpatients
- Diagnosis of DSM IV-TR of Bipolar I or Bipolar II disorder with current manic episode as verified by the semistructured interview MINI plus
- Ability to comply with the protocol
- Willingness to participate in the study
- Delayed written informed consent at discharge
Exclusion
- Inability to comply with the protocol
- Severe retinal damage, cataract or corneal damage on both eyes
- Daily use of NSAIDS
- Daily use of betablockers
- Daily use of calcium-antagonists
- NON-BIPOLAR CONTROLS
- Inclusion Criteria:
- Written informed consent
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01818622
Start Date
February 1 2012
End Date
March 1 2015
Last Update
March 19 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Haugesund Hospital and Haugaland District Psychiatric Hospital
Haugesund, Norway, 5521
2
Valen Hospital and Folgfonn District Hospital
Valen, Norway, 5451